GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies

Haematologica

Volumn 100, Issue 10, 2015, Pages e398-e401

  Wang, Xinan ^a   Muramatsu, Hideki ^a   Okuno, Yusuke ^a   Sakaguchi, Hirotoshi ^a   Yoshida, Kenichi ^b   Kawashima, Nozomu ^a   Xu, Yinyan ^a   Shiraishi, Yuichi ^c   Chiba, Kenichi ^c   Tanaka, Hiroko ^c   Saito, Shoji ^d   Nakazawa, Yozo ^d   Masunari, Taro ^e   Hirose, Tadashi ^f   Elmahdi, Shaimaa ^a   Narita, Atsushi ^a   Doisaki, Sayoko ^a   Ismael, Olfat ^a   Makishima, Hideki ^g   Hama, Asahito ^a   Miyano, Satoru ^c   Takahashi, Yoshiyuki ^a   Ogawa, Seishi ^b   Kojima, Seiji ^a   more..

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e CHUGOKU CENTRAL HOSPITAL   (Japan)

^f KAWASAKI MEDICAL SCHOOL   (Japan)

^g TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Acute myeloid leukemia; Aplastic anemia; Children; Familial myelodysplastic syndromes; GATA2; Juvenile myelomonocytic leukemia; Monosomy 7; SETBP1

Indexed keywords

TRANSCRIPTION FACTOR GATA 2;

ACUTE MYELOBLASTIC LEUKEMIA; GENE; GENE MUTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; LETTER; MISSENSE MUTATION; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; SETBP1 GENE; AGE; CHILD; FAMILY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MUTATION; MYELOPROLIFERATIVE DISORDER; PEDIGREE;

AGE FACTORS; CHILD; FAMILY; GATA2 TRANSCRIPTION FACTOR; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; PEDIGREE;

EID: 84943239137     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2015.127092     Document Type: Letter

References (15)

1. Rodrigues NP, Janzen V, Forkert R, et al. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood. 2005;106(2):477-484.
2. Kazenwadel J, Secker GA, Liu YJ, et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood. 2012;119(5):1283-1291.
3. Hsu AP, Johnson KD, Falcone EL, et al. GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood. 2013;121(19):3830-3837, 1-7.
4. Hahn CN, Chong CE, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012-1017.
5. Bodor C, Renneville A, Smith M, et al. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica. 2012;97(6):890-894.
6. Zhang SJ, Ma LY, Huang QH, et al. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci U S A. 2008;105(6):2076-2081.
7. Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653-2655.
8. Dickinson RE, Griffin H, Bigley V, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood. 2011;118(10):2656-2658.
9. Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43(10):929-931.
10. Makishima H, Yoshida K, Nguyen N, et al. Somatic SETBP1 mutations in myeloid malignancies. Nat Genet. 2013;45(8):942-946.
11. Sakaguchi H, Okuno Y, Muramatsu H, et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet. 2013;45(8):937-941.
12. Fasan A, Eder C, Haferlach C, et al. GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis. Leukemia. 2013;27(2):482-485.
13. Brewin J, Horne G, Chevassut T. Genomic landscapes and clonality of de novo AML. N Engl J Med. 2013;369(15):1472-1473.
14. Stieglitz E, Liu YL, Emanuel PD, et al. Mutations in GATA2 are rare in juvenile myelomonocytic leukemia. Blood. 2014;123(9):1426-1427.
15. Haferlach T, Nagata Y, Grossmann V, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014;28(2):241-247.